glp 1 immune system Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Beyond metabolic benefits: The underexplored
Description
Interview Courtesy | Ankit Kankar #GLP1 #Diabetes #Obesity #Cardiology #Metabolism #Therapeutics #Innovation #Healthcare #Medicine #Research #Pharmacology #Biotechnology #Clinicaltrials #Prevention #Wellness
New research suggests GLP-1s may reduce the risks of blood clots and early death in people with both obesity and autoimmune disease
Power Up and Reset: Berberine Patch &
Nicola Magrini, Unit head for Innovation, Evidence synthesis and Clinical research, University Hospital, Bologna, Italy, Co-Chair of the Guidelines Development GroupComments: GLP-1 and inclusion in the essential medicineMr Deus Mubangizi, Director, Medicines and Health Products Policies and Standards Department, WHOPanel discussionMs Jeanette Hunter General Primary Health Care at the National Department of Health (NDoH) of South Africa, and Co-Chair of the Guidelines Development Group
Libro de recetas de la dieta GLP-1 para personas mayores con diabetes tipo 2: Comidas que se adaptan a tu dosis
